Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $641.86 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $286.72 | 4 | $0 (2018) |
| PFIZER INC. | $125.00 | 1 | $0 (2018) |
| Novo Nordisk Inc | $99.38 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $77.15 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $35.35 | 2 | $0 (2017) |
| Genentech USA, Inc. | $18.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $375.79 | 5 | Abbott Laboratories ($182.94) |
| 2017 | $266.07 | 7 | Abbott Laboratories ($103.78) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2018 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $165.12 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/06/2018 | Abbott Laboratories | Ensite Cardiac Mapping System (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/02/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/01/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $49.59 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Metabolism & Primary Care | ||||||
| 12/01/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2017 | Abbott Laboratories | Pacemakers (Device) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/19/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2017 | Abbott Laboratories | Cardiac Mapping System (Device) | Food and Beverage | In-kind items and services | $92.98 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/23/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $99.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 231 | 402 | $99,105 | $31,907 |
| 2022 | 6 | 228 | 434 | $104,831 | $33,358 |
| 2021 | 5 | 168 | 277 | $79,787 | $21,243 |
| 2020 | 6 | 277 | 378 | $154,144 | $37,844 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 136 | $37,243 | $12,523 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 94 | $17,981 | $5,916 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 53 | 55 | $15,097 | $4,942 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $11,723 | $3,307 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $10,135 | $2,893 | 28.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 64 | $6,926 | $2,326 | 33.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 216 | $54,728 | $17,036 | 31.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $16,644 | $5,441 | 32.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 46 | 47 | $12,287 | $4,013 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 61 | $10,761 | $3,483 | 32.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 63 | $6,070 | $1,963 | 32.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $4,341 | $1,423 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 75 | 150 | $44,755 | $11,858 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 42 | 42 | $13,206 | $3,529 | 26.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 47 | $9,172 | $2,649 | 28.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $10,254 | $2,598 | 25.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 21 | $2,400 | $608.80 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 104 | 182 | $55,692 | $14,657 | 26.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 57 | 58 | $34,452 | $8,975 | 26.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 21 | 42 | $34,482 | $6,987 | 20.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 62 | 63 | $19,782 | $5,189 | 26.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 19 | $4,066 | $1,031 | 25.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $5,670 | $1,005 | 17.7% |
About Dr. Michael Javid, DO
Dr. Michael Javid, DO is a Internal Medicine healthcare provider based in Newport, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750768511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Javid, DO has received a total of $641.86 in payments from pharmaceutical and medical device companies, with $375.79 received in 2018. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($641.86).
As a Medicare-enrolled provider, Javid has provided services to 904 Medicare beneficiaries, totaling 1,491 services with total Medicare billing of $124,352. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Newport, OR
- Active Since 04/30/2015
- Last Updated 09/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750768511
Products in Payments
- Merlin Connectivity and Remote (Device) $165.12
- ELIQUIS (Drug) $125.00
- Tresiba (Drug) $99.38
- Cardiac Mapping System (Device) $92.98
- ANORO (Drug) $49.59
- XARELTO (Drug) $35.35
- ANORO ELLIPTA (Drug) $27.56
- Activase (Biological) $18.26
- Ensite Cardiac Mapping System (Device) $17.82
- Pacemakers (Device) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport
Candi Overholt, Md, MD
Internal Medicine — Payments: $18,838
Mr. Anton Daniel, Md, MD
Internal Medicine — Payments: $18,405
Niva Khan, M.d, M.D
Internal Medicine — Payments: $6,286
Vijoydeep Tanjore Venkoba Rao, Md, MD
Internal Medicine — Payments: $5,723
Dr. Adrian Velasquez, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $5,261
Abby Lauer, Md, MD
Internal Medicine — Payments: $3,626